Interleukin 1 Trials in Cancer Patients: A Review of the Toxicity, Antitumor and Hematopoietic Effects

Stem Cells - United States
doi 10.1002/stem.140164
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Interleukin 1 Trials in Cancer Patients: A Review of the Toxicity, Antitumor and Hematopoietic Effects

Oncologist
Cancer ResearchMedicineOncology
1996English

Multilineage Hematopoietic Recovery With Concomitant Antitumor Effects Using Low Dose Interleukin-12 in Myelosuppressed Tumor-Bearing Mice

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2008English

The Effects of Vitamin D Supplementation in Newly Diagnosed Type 1 Diabetes Patients: Systematic Review of Randomized Controlled Trials

Review of Diabetic Studies
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Phase 1 Clinical Trials in 83 Patients With Pancreatic Cancer

Cancer
Cancer ResearchOncology
2010English

Herbal Medicine for Xerostomia in Cancer Patients: A Systematic Review of Randomized Controlled Trials

Integrative Cancer Therapies
OncologyAlternative MedicineComplementary
2017English

Assessing Toxicity in Cancer Chemoprevention Trials: The Other Side of the Coin

Cancer Prevention Research
MedicineCancer ResearchOncology
2008English

Interleukin-1 and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Gastric Cancer: A Meta-Analysis

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2006English

Antitumor Effects of the Silencing of Programmed Cell Death Ligand�1 in Colorectal Cancer via Immunoregulation

Oncology Reports
MedicineCancer ResearchOncology
2018English

Pharmacokinetic Evaluation of Novel Oral Fluorouracil Antitumor Drug S-1 in Chinese Cancer Patients

Acta Pharmacologica Sinica
MedicinePharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy